147 related articles for article (PubMed ID: 2842381)
1. Glucagonoma syndrome.
Hashizume T; Kiryu H; Noda K; Kano T; Nakano R
J Am Acad Dermatol; 1988 Aug; 19(2 Pt 2):377-83. PubMed ID: 2842381
[TBL] [Abstract][Full Text] [Related]
2. [Glucagonoma syndrome with normal blood glucagon ].
Quencez E; Zultak M; Blanc D; Gillet M; Laurent R
Ann Dermatol Venereol; 1987; 114(9):1103-8. PubMed ID: 2829690
[No Abstract] [Full Text] [Related]
3. Necrolytic migratory erythema: a cutaneous clue to glucagonoma syndrome.
Remes-Troche JM; García-de-Acevedo B; Zuñiga-Varga J; Avila-Funes A; Orozco-Topete R
J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):591-5. PubMed ID: 15324403
[TBL] [Abstract][Full Text] [Related]
4. Histologic variation in the skin lesions of the glucagonoma syndrome.
Kheir SM; Omura EF; Grizzle WE; Herrera GA; Lee I
Am J Surg Pathol; 1986 Jul; 10(7):445-53. PubMed ID: 3014912
[TBL] [Abstract][Full Text] [Related]
5. Effect of somatostatin on skin lesions and concentrations of plasma amino acids in a patient with glucagonoma-syndrome.
Schmid R; Allescher HD; Schepp W; Hölscher A; Siewert R; Schusdziarra V; Classen M
Hepatogastroenterology; 1988 Feb; 35(1):34-7. PubMed ID: 2896149
[TBL] [Abstract][Full Text] [Related]
6. Glucagonoma syndrome. A clinicopathologic, immunocytochemical, and ultrastructural study.
Vandersteen PR; Scheithauer BW
J Am Acad Dermatol; 1985 Jun; 12(6):1032-9. PubMed ID: 2989344
[TBL] [Abstract][Full Text] [Related]
7. Papulosquamous eruption with weight loss: Necrolytic migratory erythema (glucagonoma syndrome).
Skouge JW; Farmer ER
Arch Dermatol; 1985 Mar; 121(3):400, 403. PubMed ID: 2983618
[No Abstract] [Full Text] [Related]
8. [Glucagonoma and somatostatinoma].
Yoshida H; Shimizu N
Nihon Rinsho; 1982 Feb; 40(2):441-5. PubMed ID: 6283209
[No Abstract] [Full Text] [Related]
9. [A case of glucagonoma].
Numakawa T; Ikeuchi T; Sugimasa T; Inoue S; Takamura Y; Suda T
Nihon Naika Gakkai Zasshi; 1982 Jul; 71(7):977-84. PubMed ID: 6294199
[No Abstract] [Full Text] [Related]
10. Somatostatin analogue in treatment of coexisting glucagonoma and pancreatic pseudocyst: dissociation of responses.
Moattari AR; Cho K; Vinik AI
Surgery; 1990 Sep; 108(3):581-7. PubMed ID: 2168587
[TBL] [Abstract][Full Text] [Related]
11. Glucagonoma syndrome demonstrating giant duodenal villi.
Stevens FM; Flanagan RW; O'Gorman D; Buchanan KD
Gut; 1984 Jul; 25(7):784-91. PubMed ID: 6329923
[TBL] [Abstract][Full Text] [Related]
12. The glucagonoma syndrome: stimulus-induced plasma responses of circulating glucagon components IRG9000 and IRG3500.
Hendriks T; Jansen JB; van Tongeren JH
Acta Endocrinol (Copenh); 1984 Feb; 105(2):226-32. PubMed ID: 6141691
[TBL] [Abstract][Full Text] [Related]
13. Glucagonoma syndrome: case report and literature review.
Parker CM; Hanke CW; Madura JA; Liss EC
J Dermatol Surg Oncol; 1984 Nov; 10(11):884-9. PubMed ID: 6092443
[TBL] [Abstract][Full Text] [Related]
14. The glucagonoma syndrome in a Chinese man.
Lee KO; Chan HL; Lee HL
Ann Acad Med Singap; 1985 Apr; 14(2):312-6. PubMed ID: 2994543
[TBL] [Abstract][Full Text] [Related]
15. Secretory response and immunochemical heterogeneity of glucagon in plasma and tumor extracts of a patient with glucagonoma.
Torre L; Vazquez JA; Blázquez E
Horm Res; 1986; 23(3):159-66. PubMed ID: 3005153
[TBL] [Abstract][Full Text] [Related]
16. [Glucagonoma syndrome with a normal blood glucose curve].
González de Zárate Apiñariz P; Alonso Alonso J; Vázquez García JA; Hernández Calvo J; Burgos Bretones J; Aguirre Errasti C; Díaz Pérez JL
Med Clin (Barc); 1983 Oct; 81(9):396-8. PubMed ID: 6316044
[No Abstract] [Full Text] [Related]
17. Additional tests of interest to the dermatologist.
Farmer KL
Dermatol Clin; 1994 Jan; 12(1):191-9. PubMed ID: 7511490
[TBL] [Abstract][Full Text] [Related]
18. Clinical experience in diagnosis and treatment of glucagonoma syndrome.
Zhang M; Xu X; Shen Y; Hu ZH; Wu LM; Zheng SS
Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):473-5. PubMed ID: 15313692
[TBL] [Abstract][Full Text] [Related]
19. Recurrent pheochromocytoma associated with glucagonoma. A case report.
Yao H; Fukiyama K; Kawano Y; Mizumoto K; Toyoshima S; Omae T
Endocrinol Jpn; 1983 Apr; 30(2):163-6. PubMed ID: 6139277
[TBL] [Abstract][Full Text] [Related]
20. A postmortem study of malignant glucagonoma with heart muscle hypertrophy, including chemical, histochemical, immunohistological and ultrastructural observations.
Takemiya M; Miyayama H; Takeya M; Takeuchi T; Konno T; Kitoh M; Fukushima H
Hum Pathol; 1981 Nov; 12(11):988-99. PubMed ID: 6274784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
